US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lexaria Bioscience Corp

0.7250

+0.06309.52%

Post-market: 0.7000-0.0250-3.45%19:58 EST

Volume:333.50K

Turnover:241.27K

Market Cap:18.04M

PE:-1.29

High:0.7949

Open:0.6700

Low:0.6700

Close:0.6620

52wk High:1.91

52wk Low:0.4600

Shares:24.89M

Float Shares:23.45M

Volume Ratio:1.49

T/O Rate:1.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5629

EPS(LYR):-0.6613

ROE:-155.23%

ROA:-82.96%

PB:3.67

PE(LYR):-1.10

Loading ...

Overview Company News Filings

Lexaria Bioscience Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Lexaria Bioscience Reports Positive Results for Oral Liraglutide in Human Pilot Study

Lexaria Bioscience Corp. Held Annual Shareholder Meeting

Lexaria Bioscience Corp. Granted Six New Patents, Bringing Total to 60 Worldwide

Lexaria Bioscience Q1 net loss narrows to USD 1.6 million

Lexaria CEO says ‘closer to a commercial breakthrough than ever before’

Lexaria Bioscience Corp. Pursues Pharmaceutical Partnerships and Reports Progress on Technology Development

Lexaria Bioscience Reports Positive Results from Phase 1b GLP-1-H24-4 Clinical Study

Lexaria Bioscience Is Maintained at Buy by HC Wainwright & Co.

Lexaria Bioscience Corp. : H.c. Wainwright Cuts Target Price to $1.5 From $4

THOMSON REUTERS

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

Benzinga_recent_news

Lexaria Bioscience Achieves Primary Endpoint in GLP-1 Clinical Study with DehydraTECH Outperforming Rybelsus

Lexaria Bioscience Issues Warrants to Purchase 2.66 Million Shares

Top Midday Decliners

MT Newswires Live

Lexaria Bioscience FY IP Licensing Revenue Rises to USD 0.7 Million, Up 52%

Lexaria Bioscience Extends Material Transfer Agreement with Pharmaceutical Company

Lexaria Bioscience Corp. Awarded Four New Patents Covering Diabetes, Epilepsy, Antiviral Treatments, and More

BRIEF-Lexaria Bioscience enters securities purchase agreement with investors - SEC filing

Lexaria Bioscience Corp - Enters Securities Purchase Agreement With Investors - SEC Filing

THOMSON REUTERS

Nasdaq Gains 100 Points; US Consumer Sentiment Falls

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LEXX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LEXX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXX\",,,,,undefined,":{"symbol":"LEXX","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":0.725,"timestamp":1770411600000,"preClose":0.662,"halted":0,"volume":333496,"hourTrading":{"tag":"盘后","latestPrice":0.7,"preClose":0.725,"latestTime":"19:58 EST","volume":1007,"amount":704.97,"timestamp":1770425905573,"change":-0.025,"changeRate":-0.034483,"amplitude":0.034483},"delay":0,"changeRate":0.09516616314199387,"floatShares":23453700,"shares":24887446,"eps":-0.562858,"marketStatus":"Market Closed","change":0.063,"latestTime":"02-06 16:00:00 EST","open":0.67,"high":0.7949,"low":0.67,"amount":241274.9514128,"amplitude":0.188671,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.562858,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.662,"preHourTrading":{"tag":"盘前","latestPrice":0.67,"preClose":0.662,"latestTime":"08:50 EST","volume":15892,"amount":10527.383646799999,"timestamp":1770385807294,"change":0.008,"changeRate":0.012085,"amplitude":0.012085},"postHourTrading":{"tag":"盘后","latestPrice":0.7,"preClose":0.725,"latestTime":"19:58 EST","volume":1007,"amount":704.97,"timestamp":1770425905573,"change":-0.025,"changeRate":-0.034483,"amplitude":0.034483},"volumeRatio":1.4894026295236538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXX\",,,,,undefined,":{"symbol":"LEXX","floatShares":23453700,"roa":"-82.96%","roe":"-155.23%","lyrEps":-0.66126,"volumeRatio":1.4894026295236538,"shares":24887446,"dividePrice":0,"high":0.7949,"amplitude":0.188671,"preClose":0.662,"low":0.67,"week52Low":0.46,"pbRate":"3.67","psRate":"34.57","week52High":1.911,"institutionHeld":0,"latestPrice":0.725,"eps":-0.562858,"divideRate":0,"volume":333496,"delay":0,"ttmEps":-0.562858,"open":0.67,"prevYearClose":0.617,"prevWeekClose":0.7837,"prevMonthClose":0.7837,"prevQuarterClose":0.617,"fiveDayClose":0.7837,"twentyDayClose":0.695,"sixtyDayClose":1.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LEXX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-13","symbol":"LEXX","fiscalQuarterEnding":"2025/11","expectedEps":-0.13,"name":null,"time":"","type":"earning","dateTimestamp":1768280400000,"reportTimeType":"","actualEps":-0.07},{"date":"2025-11-28","symbol":"LEXX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1764320400000,"name":null,"time":"Pre-Market","dateTimestamp":1764306000000,"actualEps":null},{"market":"US","date":"2025-07-14","symbol":"LEXX","fiscalQuarterEnding":"2025/05","expectedEps":-0.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1752465600000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2025-04-14","symbol":"LEXX","fiscalQuarterEnding":"2025/02","expectedEps":-0.16,"name":null,"time":"","type":"earning","dateTimestamp":1744603200000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2025-01-10","symbol":"LEXX","fiscalQuarterEnding":"2024/11","expectedEps":-0.12,"name":null,"time":"","type":"earning","dateTimestamp":1736485200000,"reportTimeType":"","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LEXX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LEXX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1720587600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LEXX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LEXX","date":"2026-02-06","current":-1.288069,"percent":0.87408,"low":-15.58291,"twenty":-8.555297,"median":-2.647022,"eighty":-1.815946,"high":-0.671866,"avg":-4.758991,"sd":3.686805,"marketCap":16475489},"quantilePoints":[{"date":"2021-02-12","current":-9.556795,"twenty":-23.795122,"median":-11.682441,"eighty":-6.324753,"marketCap":35577194},{"date":"2021-02-19","current":-9.460815,"twenty":-23.771743,"median":-11.640151,"eighty":-6.324753,"marketCap":35219890},{"date":"2021-02-26","current":-8.199373,"twenty":-23.771743,"median":-11.551652,"eighty":-6.338908,"marketCap":30523905},{"date":"2021-03-05","current":-7.472673,"twenty":-23.697068,"median":-11.526163,"eighty":-6.350317,"marketCap":27818609},{"date":"2021-03-12","current":-8.720404,"twenty":-23.572608,"median":-11.512737,"eighty":-6.355133,"marketCap":32463551},{"date":"2021-03-19","current":-8.281641,"twenty":-23.448149,"median":-11.410887,"eighty":-6.360832,"marketCap":30830165},{"date":"2021-03-26","current":-7.362982,"twenty":-23.311037,"median":-11.367864,"eighty":-6.363763,"marketCap":27410262},{"date":"2021-04-01","current":-7.664631,"twenty":-23.161686,"median":-11.265208,"eighty":-6.368341,"marketCap":28533215},{"date":"2021-04-09","current":-7.513807,"twenty":-22.975203,"median":-11.171334,"eighty":-6.375521,"marketCap":27971739},{"date":"2021-04-16","current":-10.69035,"twenty":-22.893692,"median":-11.040265,"eighty":-6.389754,"marketCap":25317486},{"date":"2021-04-23","current":-11.487816,"twenty":-22.828043,"median":-11.033138,"eighty":-6.411854,"marketCap":27206089},{"date":"2021-04-30","current":-10.905881,"twenty":-22.707615,"median":-11.034169,"eighty":-6.417931,"marketCap":25827919},{"date":"2021-05-07","current":-13.492257,"twenty":-22.552041,"median":-11.047392,"eighty":-6.425699,"marketCap":31953118},{"date":"2021-05-14","current":-13.341385,"twenty":-22.400201,"median":-11.099089,"eighty":-6.436417,"marketCap":31595815},{"date":"2021-05-21","current":-12.500813,"twenty":-22.351461,"median":-11.172121,"eighty":-6.446058,"marketCap":29605125},{"date":"2021-05-28","current":-13.1043,"twenty":-22.231879,"median":-11.265208,"eighty":-6.458512,"marketCap":31034338},{"date":"2021-06-04","current":-14.89321,"twenty":-22.149928,"median":-11.367864,"eighty":-6.465205,"marketCap":35270934},{"date":"2021-06-11","current":-14.117297,"twenty":-22.118803,"median":-11.410887,"eighty":-6.469175,"marketCap":33433374},{"date":"2021-06-18","current":-14.634572,"twenty":-22.031695,"median":-11.455486,"eighty":-6.472151,"marketCap":34658414},{"date":"2021-06-25","current":-15.087188,"twenty":-21.904299,"median":-11.502925,"eighty":-6.477978,"marketCap":35730324},{"date":"2021-07-02","current":-14.806997,"twenty":-21.780393,"median":-11.526163,"eighty":-6.487355,"marketCap":35066760},{"date":"2021-07-09","current":-15.58291,"twenty":-21.780393,"median":-11.527325,"eighty":-6.499229,"marketCap":36904320},{"date":"2021-07-16","current":-9.056977,"twenty":-21.678409,"median":-11.528487,"eighty":-6.499229,"marketCap":33280244},{"date":"2021-07-23","current":-9.404254,"twenty":-21.573706,"median":-11.526163,"eighty":-6.500409,"marketCap":34556327},{"date":"2021-07-30","current":-9.637817,"twenty":-21.453183,"median":-11.522549,"eighty":-6.505772,"marketCap":35414565},{"date":"2021-08-06","current":-9.560467,"twenty":-21.332659,"median":-11.488954,"eighty":-6.51288,"marketCap":35130339},{"date":"2021-08-13","current":-8.523977,"twenty":-21.212135,"median":-11.423157,"eighty":-6.524386,"marketCap":31321710},{"date":"2021-08-20","current":-8.988077,"twenty":-21.193975,"median":-11.406136,"eighty":-6.528671,"marketCap":33027067},{"date":"2021-08-27","current":-9.421237,"twenty":-21.072867,"median":-11.284971,"eighty":-6.542848,"marketCap":34618732},{"date":"2021-09-03","current":-9.746108,"twenty":-20.982035,"median":-11.189873,"eighty":-6.542848,"marketCap":35812482},{"date":"2021-09-10","current":-9.544997,"twenty":-20.824181,"median":-11.135597,"eighty":-6.542848,"marketCap":35073494},{"date":"2021-09-17","current":-9.777048,"twenty":-20.724576,"median":-11.078307,"eighty":-6.542848,"marketCap":35926172},{"date":"2021-09-24","current":-10.612428,"twenty":-20.701837,"median":-11.034169,"eighty":-6.558291,"marketCap":38995814},{"date":"2021-10-01","current":-9.869868,"twenty":-20.531178,"median":-10.981495,"eighty":-6.611265,"marketCap":36267243},{"date":"2021-10-08","current":-10.179268,"twenty":-20.488995,"median":-10.949822,"eighty":-6.633734,"marketCap":37404148},{"date":"2021-10-15","current":-10.581488,"twenty":-20.488995,"median":-10.905881,"eighty":-6.655994,"marketCap":38882123},{"date":"2021-10-22","current":-10.194738,"twenty":-20.471658,"median":-10.86231,"eighty":-6.666084,"marketCap":37460993},{"date":"2021-10-29","current":-9.575937,"twenty":-20.436451,"median":-10.830411,"eighty":-6.668536,"marketCap":35187184},{"date":"2021-11-05","current":-9.715167,"twenty":-20.327206,"median":-10.804878,"eighty":-6.791676,"marketCap":35698791},{"date":"2021-11-12","current":-10.148328,"twenty":-20.143564,"median":-10.737922,"eighty":-6.827422,"marketCap":37290457},{"date":"2021-11-19","current":-8.616797,"twenty":-20.02632,"median":-10.690687,"eighty":-6.849445,"marketCap":31662781},{"date":"2021-11-26","current":-8.260987,"twenty":-20.0069,"median":-10.671553,"eighty":-6.863479,"marketCap":30355342},{"date":"2021-12-03","current":-6.840174,"twenty":-19.934586,"median":-10.612428,"eighty":-6.863479,"marketCap":27545422},{"date":"2021-12-10","current":-7.025044,"twenty":-19.741749,"median":-10.596796,"eighty":-6.863479,"marketCap":28289893},{"date":"2021-12-17","current":-6.531754,"twenty":-19.615799,"median":-10.578981,"eighty":-6.826164,"marketCap":26303411},{"date":"2021-12-23","current":-6.191866,"twenty":-19.51938,"median":-10.535078,"eighty":-6.679019,"marketCap":24934681},{"date":"2021-12-31","current":-5.955422,"twenty":-19.356074,"median":-10.473198,"eighty":-6.628639,"marketCap":23982521},{"date":"2022-01-07","current":-6.443087,"twenty":-19.236954,"median":-10.457728,"eighty":-6.542848,"marketCap":25946351},{"date":"2022-01-14","current":-5.152781,"twenty":-19.117133,"median":-10.426788,"eighty":-6.542848,"marketCap":27434100},{"date":"2022-01-21","current":-5.052184,"twenty":-18.967952,"median":-10.401429,"eighty":-6.525243,"marketCap":26898510},{"date":"2022-01-28","current":-4.560379,"twenty":-18.668908,"median":-10.364908,"eighty":-6.502913,"marketCap":24280071},{"date":"2022-02-04","current":-4.392718,"twenty":-18.668908,"median":-10.347469,"eighty":-6.489782,"marketCap":23387422},{"date":"2022-02-11","current":-4.007097,"twenty":-18.667483,"median":-10.341251,"eighty":-6.469175,"marketCap":21334327},{"date":"2022-02-18","current":-4.314476,"twenty":-18.617444,"median":-10.333079,"eighty":-6.440892,"marketCap":22970852},{"date":"2022-02-25","current":-3.889735,"twenty":-18.440095,"median":-10.297161,"eighty":-6.416353,"marketCap":20709473},{"date":"2022-03-04","current":-3.710896,"twenty":-18.35776,"median":-10.259288,"eighty":-6.37702,"marketCap":19757313},{"date":"2022-03-11","current":-3.744429,"twenty":-18.272902,"median":-10.22525,"eighty":-6.357467,"marketCap":19935843},{"date":"2022-03-18","current":-3.107317,"twenty":-18.171071,"median":-10.224763,"eighty":-6.324865,"marketCap":16543774},{"date":"2022-03-25","current":-3.845025,"twenty":-17.891037,"median":-10.197982,"eighty":-6.318961,"marketCap":20471433},{"date":"2022-04-01","current":-3.688542,"twenty":-17.881648,"median":-10.179268,"eighty":-6.279787,"marketCap":19638293},{"date":"2022-04-08","current":-3.39234,"twenty":-17.785381,"median":-10.153858,"eighty":-6.221421,"marketCap":18061278},{"date":"2022-04-14","current":-3.185945,"twenty":-17.768281,"median":-10.122944,"eighty":-6.204693,"marketCap":22792322},{"date":"2022-04-22","current":-2.495518,"twenty":-17.575778,"median":-10.086448,"eighty":-6.185731,"marketCap":17852994},{"date":"2022-04-29","current":-2.312514,"twenty":-17.497699,"median":-10.042063,"eighty":-6.147983,"marketCap":16543774},{"date":"2022-05-06","current":-2.370742,"twenty":-17.489943,"median":-9.984656,"eighty":-6.122035,"marketCap":16960344},{"date":"2022-05-13","current":-1.705271,"twenty":-17.39456,"median":-9.962688,"eighty":-6.105634,"marketCap":12199545},{"date":"2022-05-20","current":-1.671997,"twenty":-17.285936,"median":-9.940712,"eighty":-6.09087,"marketCap":11961505},{"date":"2022-05-27","current":-1.713589,"twenty":-17.264742,"median":-9.93387,"eighty":-6.058044,"marketCap":12259055},{"date":"2022-06-03","current":-1.81341,"twenty":-17.257904,"median":-9.920751,"eighty":-6.023867,"marketCap":12973175},{"date":"2022-06-10","current":-1.988096,"twenty":-17.136229,"median":-9.900808,"eighty":-6.017376,"marketCap":14222885},{"date":"2022-06-17","current":-1.938186,"twenty":-17.051331,"median":-9.885602,"eighty":-5.98861,"marketCap":13865825},{"date":"2022-06-24","current":-2.736752,"twenty":-17.004275,"median":-9.878747,"eighty":-5.959552,"marketCap":19578783},{"date":"2022-07-01","current":-2.295877,"twenty":-16.835329,"median":-9.865791,"eighty":-5.937004,"marketCap":16424754},{"date":"2022-07-08","current":-2.428971,"twenty":-16.675346,"median":-9.823458,"eighty":-5.903478,"marketCap":17376914},{"date":"2022-07-15","current":-2.438392,"twenty":-16.66574,"median":-9.800253,"eighty":-5.868301,"marketCap":17019854},{"date":"2022-07-22","current":-2.387237,"twenty":-16.651735,"median":-9.761578,"eighty":-5.823139,"marketCap":16662794},{"date":"2022-07-29","current":-2.301978,"twenty":-16.589073,"median":-9.747431,"eighty":-5.807068,"marketCap":16067694},{"date":"2022-08-05","current":-2.408551,"twenty":-16.505285,"median":-9.746108,"eighty":-5.766272,"marketCap":16811569},{"date":"2022-08-12","current":-2.796477,"twenty":-16.452472,"median":-9.699697,"eighty":-5.752153,"marketCap":19519273},{"date":"2022-08-19","current":-2.361659,"twenty":-16.36772,"median":-9.668758,"eighty":-5.723569,"marketCap":16484264},{"date":"2022-08-26","current":-2.472495,"twenty":-16.30819,"median":-9.653288,"eighty":-5.719391,"marketCap":17257894},{"date":"2022-09-02","current":-2.544965,"twenty":-16.294271,"median":-9.637817,"eighty":-5.698952,"marketCap":17763729},{"date":"2022-09-09","current":-2.702693,"twenty":-16.238593,"median":-9.622347,"eighty":-5.63867,"marketCap":18864663},{"date":"2022-09-16","current":-2.417077,"twenty":-16.234654,"median":-9.606878,"eighty":-5.600553,"marketCap":16871079},{"date":"2022-09-23","current":-2.105884,"twenty":-16.195923,"median":-9.584217,"eighty":-5.561251,"marketCap":14698965},{"date":"2022-09-30","current":-2.088832,"twenty":-16.194972,"median":-9.568073,"eighty":-5.554352,"marketCap":14579945},{"date":"2022-10-07","current":-1.884212,"twenty":-16.117012,"median":-9.560467,"eighty":-5.500415,"marketCap":13151705},{"date":"2022-10-14","current":-1.798953,"twenty":-16.06593,"median":-9.544081,"eighty":-5.437212,"marketCap":12556605},{"date":"2022-10-21","current":-1.756324,"twenty":-16.055261,"median":-9.518871,"eighty":-5.376914,"marketCap":12259055},{"date":"2022-10-28","current":-1.901263,"twenty":-16.055261,"median":-9.506322,"eighty":-5.316693,"marketCap":13270725},{"date":"2022-11-04","current":-1.853092,"twenty":-16.018697,"median":-9.483058,"eighty":-5.249722,"marketCap":12934494},{"date":"2022-11-11","current":-2.012099,"twenty":-15.999369,"median":-9.465212,"eighty":-5.161838,"marketCap":14044355},{"date":"2022-11-18","current":-1.875686,"twenty":-15.953664,"median":-9.433393,"eighty":-5.052184,"marketCap":13092195},{"date":"2022-11-25","current":-2.020625,"twenty":-15.921079,"median":-9.421237,"eighty":-4.916007,"marketCap":14103865},{"date":"2022-12-02","current":-2.414922,"twenty":-15.800117,"median":-9.406458,"eighty":-4.808471,"marketCap":17554849},{"date":"2022-12-09","current":-2.398631,"twenty":-15.771913,"median":-9.374504,"eighty":-4.781462,"marketCap":17436424},{"date":"2022-12-16","current":-2.193969,"twenty":-15.76565,"median":-9.351067,"eighty":-4.644331,"marketCap":15948674},{"date":"2022-12-23","current":-2.005681,"twenty":-15.66997,"median":-9.282007,"eighty":-4.550807,"marketCap":14579945},{"date":"2022-12-30","current":-2.013867,"twenty":-15.646442,"median":-9.280758,"eighty":-4.497998,"marketCap":14639455},{"date":"2023-01-06","current":-2.202156,"twenty":-15.566057,"median":-9.2003,"eighty":-4.46149,"marketCap":16008184},{"date":"2023-01-13","current":-2.267647,"twenty":-15.371731,"median":-9.154215,"eighty":-4.348865,"marketCap":16484264},{"date":"2023-01-20","current":-2.301829,"twenty":-15.296539,"median":-9.072941,"eighty":-4.332713,"marketCap":16186714},{"date":"2023-01-27","current":-2.488006,"twenty":-15.134452,"median":-8.999523,"eighty":-4.281096,"marketCap":17495934},{"date":"2023-02-03","current":-2.547244,"twenty":-15.061324,"median":-8.939785,"eighty":-4.234421,"marketCap":17912503},{"date":"2023-02-10","current":-2.377992,"twenty":-14.980795,"median":-8.912362,"eighty":-4.200782,"marketCap":16722304},{"date":"2023-02-17","current":-2.572378,"twenty":-14.909476,"median":-8.88494,"eighty":-4.07975,"marketCap":18089248},{"date":"2023-02-24","current":-2.538782,"twenty":-14.844896,"median":-8.819202,"eighty":-4.017157,"marketCap":17852994},{"date":"2023-03-03","current":-2.648795,"twenty":-14.786699,"median":-8.718288,"eighty":-3.831612,"marketCap":18626623},{"date":"2023-03-10","current":-2.488006,"twenty":-14.7336,"median":-8.624543,"eighty":-3.777961,"marketCap":17495934},{"date":"2023-03-17","current":-2.157964,"twenty":-14.643442,"median":-8.603064,"eighty":-3.688542,"marketCap":15175044},{"date":"2023-03-24","current":-2.127971,"twenty":-14.519701,"median":-8.554917,"eighty":-3.567825,"marketCap":14964125},{"date":"2023-03-31","current":-2.315232,"twenty":-14.463957,"median":-8.486299,"eighty":-3.391222,"marketCap":16280968},{"date":"2023-04-06","current":-1.979013,"twenty":-14.378658,"median":-8.403234,"eighty":-3.335336,"marketCap":13916636},{"date":"2023-04-14","current":-1.966245,"twenty":-14.287498,"median":-8.311435,"eighty":-3.154494,"marketCap":13826851},{"date":"2023-04-21","current":-1.907234,"twenty":-14.209652,"median":-8.249563,"eighty":-2.791565,"marketCap":13168430},{"date":"2023-04-28","current":-1.892843,"twenty":-14.052638,"median":-8.158239,"eighty":-2.73978,"marketCap":13069068},{"date":"2023-05-05","current":-1.187686,"twenty":-13.914167,"median":-8.083856,"eighty":-2.69968,"marketCap":8200340},{"date":"2023-05-12","current":-0.679495,"twenty":-13.712693,"median":-7.963612,"eighty":-2.682794,"marketCap":4691552},{"date":"2023-05-19","current":-1.035296,"twenty":-13.580704,"median":-7.870301,"eighty":-2.589574,"marketCap":7148163},{"date":"2023-05-26","current":-0.878958,"twenty":-13.460618,"median":-7.865587,"eighty":-2.570177,"marketCap":6068737},{"date":"2023-06-02","current":-0.890678,"twenty":-13.412897,"median":-7.788843,"eighty":-2.562883,"marketCap":6149654},{"date":"2023-06-07","current":-0.891264,"twenty":-13.379485,"median":-7.750301,"eighty":-2.551939,"marketCap":6153699},{"date":"2023-06-15","current":-0.846378,"twenty":-13.234305,"median":-7.6805,"eighty":-2.544965,"marketCap":5843789},{"date":"2023-06-23","current":-0.978573,"twenty":-13.163346,"median":-7.611749,"eighty":-2.520854,"marketCap":6756527},{"date":"2023-06-30","current":-0.870169,"twenty":-13.029994,"median":-7.521467,"eighty":-2.513394,"marketCap":6008050},{"date":"2023-07-07","current":-0.902397,"twenty":-12.943419,"median":-7.472673,"eighty":-2.504275,"marketCap":6230570},{"date":"2023-07-14","current":-0.972714,"twenty":-12.889745,"median":-7.435218,"eighty":-2.488006,"marketCap":6716069},{"date":"2023-07-21","current":-0.892153,"twenty":-12.803082,"median":-7.349407,"eighty":-2.465674,"marketCap":6149654},{"date":"2023-07-28","current":-0.933239,"twenty":-12.729177,"median":-7.31323,"eighty":-2.440772,"marketCap":6432861},{"date":"2023-08-04","current":-0.987238,"twenty":-12.617531,"median":-7.225926,"eighty":-2.428809,"marketCap":6805077},{"date":"2023-08-11","current":-1.197364,"twenty":-12.500813,"median":-7.101059,"eighty":-2.42134,"marketCap":8253483},{"date":"2023-08-18","current":-1.220842,"twenty":-12.383388,"median":-7.064426,"eighty":-2.41243,"marketCap":8415316},{"date":"2023-08-25","current":-1.279536,"twenty":-12.336572,"median":-6.955491,"eighty":-2.398735,"marketCap":8819898},{"date":"2023-09-01","current":-1.232463,"twenty":-12.11462,"median":-6.875913,"eighty":-2.387237,"marketCap":8495423},{"date":"2023-09-08","current":-1.013064,"twenty":-12.086798,"median":-6.828681,"eighty":-2.377992,"marketCap":6983093},{"date":"2023-09-15","current":-1.115428,"twenty":-11.968099,"median":-6.668826,"eighty":-2.370742,"marketCap":7688693},{"date":"2023-09-22","current":-1.079975,"twenty":-11.813295,"median":-6.618092,"eighty":-2.362271,"marketCap":7444318},{"date":"2023-09-29","current":-1.138669,"twenty":-11.717442,"median":-6.542848,"eighty":-2.353044,"marketCap":7848900},{"date":"2023-10-06","current":-1.198664,"twenty":-11.638981,"median":-6.520681,"eighty":-2.340161,"marketCap":8262448},{"date":"2023-10-13","current":-1.276707,"twenty":-11.526163,"median":-6.499819,"eighty":-2.320472,"marketCap":8800396},{"date":"2023-10-20","current":-1.407128,"twenty":-11.488271,"median":-6.473736,"eighty":-2.310478,"marketCap":9699395},{"date":"2023-10-27","current":-1.459244,"twenty":-11.407561,"median":-6.454631,"eighty":-2.307051,"marketCap":10058632},{"date":"2023-11-03","current":-1.863141,"twenty":-11.200524,"median":-6.416353,"eighty":-2.296343,"marketCap":12842718},{"date":"2023-11-10","current":-2.221231,"twenty":-11.072124,"median":-6.374521,"eighty":-2.286817,"marketCap":15311046},{"date":"2023-11-17","current":-1.966568,"twenty":-10.97961,"median":-6.351632,"eighty":-2.246358,"marketCap":13555640},{"date":"2023-11-24","current":-2.019895,"twenty":-10.923124,"median":-6.324753,"eighty":-2.211171,"marketCap":13462399},{"date":"2023-12-01","current":-2.312857,"twenty":-10.83906,"median":-6.280532,"eighty":-2.210358,"marketCap":15414961},{"date":"2023-12-08","current":-2.220343,"twenty":-10.797412,"median":-6.231466,"eighty":-2.210358,"marketCap":14798363},{"date":"2023-12-15","current":-2.143248,"twenty":-10.687142,"median":-6.201269,"eighty":-2.187213,"marketCap":14284530},{"date":"2023-12-22","current":-2.066153,"twenty":-10.612428,"median":-6.179172,"eighty":-2.171698,"marketCap":13770698},{"date":"2023-12-29","current":-1.973638,"twenty":-10.596958,"median":-6.140861,"eighty":-2.157964,"marketCap":13154100},{"date":"2024-01-05","current":-2.143248,"twenty":-10.573585,"median":-6.117977,"eighty":-2.139346,"marketCap":14284530},{"date":"2024-01-12","current":-2.343696,"twenty":-10.462732,"median":-6.097421,"eighty":-2.131306,"marketCap":15620494},{"date":"2024-01-19","current":-2.742435,"twenty":-10.414921,"median":-6.060406,"eighty":-2.131152,"marketCap":16696705},{"date":"2024-01-26","current":-2.530945,"twenty":-10.363099,"median":-6.025016,"eighty":-2.131306,"marketCap":15409096},{"date":"2024-02-02","current":-2.721633,"twenty":-10.341251,"median":-6.014533,"eighty":-2.131306,"marketCap":16570056},{"date":"2024-02-09","current":-3.293696,"twenty":-10.266818,"median":-5.973923,"eighty":-2.131306,"marketCap":20052934},{"date":"2024-02-16","current":-4.091117,"twenty":-10.224822,"median":-5.937004,"eighty":-2.131306,"marketCap":24907855},{"date":"2024-02-23","current":-5.054829,"twenty":-10.196036,"median":-5.895319,"eighty":-2.131306,"marketCap":30775207},{"date":"2024-03-01","current":-7.68245,"twenty":-10.148328,"median":-5.877884,"eighty":-2.131461,"marketCap":46772892},{"date":"2024-03-08","current":-10.165167,"twenty":-10.086448,"median":-5.877884,"eighty":-2.131461,"marketCap":61888365},{"date":"2024-03-15","current":-7.827179,"twenty":-10.040038,"median":-5.877884,"eighty":-2.131461,"marketCap":47654041},{"date":"2024-03-22","current":-6.993635,"twenty":-9.962688,"median":-5.877884,"eighty":-2.131461,"marketCap":42579195},{"date":"2024-03-28","current":-7.542554,"twenty":-9.935991,"median":-5.877884,"eighty":-2.131461,"marketCap":45921166},{"date":"2024-04-05","current":-6.63909,"twenty":-9.90079,"median":-5.861912,"eighty":-2.131306,"marketCap":40420623},{"date":"2024-04-12","current":-5.945755,"twenty":-9.870325,"median":-5.861912,"eighty":-2.131306,"marketCap":32343039},{"date":"2024-04-19","current":-5.32986,"twenty":-9.807988,"median":-5.814067,"eighty":-2.131306,"marketCap":28992764},{"date":"2024-04-26","current":-5.18773,"twenty":-9.748753,"median":-5.782168,"eighty":-2.131461,"marketCap":28219623},{"date":"2024-05-03","current":-7.10648,"twenty":-9.715167,"median":-5.779641,"eighty":-2.131461,"marketCap":38657019},{"date":"2024-05-10","current":-8.527776,"twenty":-9.653288,"median":-5.779641,"eighty":-2.131461,"marketCap":46388422},{"date":"2024-05-17","current":-7.438116,"twenty":-9.622347,"median":-5.779641,"eighty":-2.131461,"marketCap":40461013},{"date":"2024-05-24","current":-6.822221,"twenty":-9.584217,"median":-5.779641,"eighty":-2.131461,"marketCap":37110738},{"date":"2024-05-31","current":-9.451618,"twenty":-9.560467,"median":-5.779641,"eighty":-2.131461,"marketCap":51413835},{"date":"2024-06-07","current":-8.077699,"twenty":-9.529527,"median":-5.779641,"eighty":-2.131461,"marketCap":43940144},{"date":"2024-06-14","current":-8.66286,"twenty":-9.498587,"median":-5.777581,"eighty":-2.131306,"marketCap":47123239},{"date":"2024-06-21","current":-7.583294,"twenty":-9.463548,"median":-5.770513,"eighty":-2.131152,"marketCap":41250738},{"date":"2024-06-28","current":-6.925022,"twenty":-9.421237,"median":-5.76339,"eighty":-2.130688,"marketCap":37669944},{"date":"2024-07-05","current":-6.951353,"twenty":-9.404254,"median":-5.76339,"eighty":-2.130688,"marketCap":37813176},{"date":"2024-07-12","current":-7.398978,"twenty":-9.312947,"median":-5.76339,"eighty":-2.130688,"marketCap":40248116},{"date":"2024-07-15","current":-9.095179,"twenty":-9.282007,"median":-5.76339,"eighty":-2.130688,"marketCap":44110471},{"date":"2024-08-02","current":-12.974484,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":62924615},{"date":"2024-08-09","current":-10.790338,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":52331778},{"date":"2024-08-16","current":-10.26875,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":49802145},{"date":"2024-08-23","current":-9.87756,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":47904921},{"date":"2024-08-30","current":-10.529544,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":51066962},{"date":"2024-09-06","current":-10.757738,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":52173676},{"date":"2024-09-13","current":-11.474921,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":55651921},{"date":"2024-09-20","current":-10.26875,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":49802145},{"date":"2024-09-27","current":-9.681965,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":46956308},{"date":"2024-10-04","current":-10.790338,"twenty":-9.20682,"median":-5.725627,"eighty":-2.124643,"marketCap":52331778},{"date":"2024-10-11","current":-9.975358,"twenty":-9.214735,"median":-5.725627,"eighty":-2.124643,"marketCap":48379227},{"date":"2024-10-18","current":-9.225576,"twenty":-9.216122,"median":-5.725627,"eighty":-2.124643,"marketCap":44742880},{"date":"2024-10-25","current":-9.824086,"twenty":-9.213308,"median":-5.725627,"eighty":-2.124643,"marketCap":47645581},{"date":"2024-10-31","current":-8.168746,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":39617388},{"date":"2024-11-08","current":-8.348674,"twenty":-9.105428,"median":-5.722197,"eighty":-2.123533,"marketCap":40490018},{"date":"2024-11-15","current":-7.628961,"twenty":-9.066105,"median":-5.722197,"eighty":-2.123533,"marketCap":36999499},{"date":"2024-11-22","current":-7.772904,"twenty":-9.020491,"median":-5.722197,"eighty":-2.123533,"marketCap":37697603},{"date":"2024-11-29","current":-6.263889,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":36301395},{"date":"2024-12-06","current":-7.046875,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":40839069},{"date":"2024-12-13","current":-6.805956,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":39442862},{"date":"2024-12-20","current":-6.655382,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":38570232},{"date":"2024-12-27","current":-7.137219,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":41362647},{"date":"2025-01-03","current":-6.926415,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":40140966},{"date":"2025-01-10","current":-6.655382,"twenty":-9.001541,"median":-5.722194,"eighty":-2.122424,"marketCap":38570232},{"date":"2025-01-17","current":-4.736024,"twenty":-8.999523,"median":-5.708343,"eighty":-2.122424,"marketCap":34666373},{"date":"2025-01-24","current":-4.364336,"twenty":-8.988077,"median":-5.687855,"eighty":-2.122424,"marketCap":31945721},{"date":"2025-01-31","current":-4.364336,"twenty":-8.953496,"median":-5.614061,"eighty":-2.122424,"marketCap":31945721},{"date":"2025-02-07","current":-4.532195,"twenty":-8.939785,"median":-5.573822,"eighty":-2.122424,"marketCap":33174402},{"date":"2025-02-14","current":-3.66892,"twenty":-8.895257,"median":-5.554362,"eighty":-2.122424,"marketCap":26855468},{"date":"2025-02-21","current":-3.429121,"twenty":-8.720404,"median":-5.505891,"eighty":-2.122424,"marketCap":25100209},{"date":"2025-02-28","current":-3.716879,"twenty":-8.66286,"median":-5.444257,"eighty":-2.122424,"marketCap":27206520},{"date":"2025-03-07","current":-3.309222,"twenty":-8.674369,"median":-5.376914,"eighty":-2.120821,"marketCap":24222579},{"date":"2025-03-14","current":-3.165343,"twenty":-8.674369,"median":-5.344313,"eighty":-2.120821,"marketCap":23169424},{"date":"2025-03-21","current":-3.788819,"twenty":-8.674369,"median":-5.316693,"eighty":-2.120821,"marketCap":27733098},{"date":"2025-03-28","current":-4.196477,"twenty":-8.674369,"median":-5.211418,"eighty":-2.120821,"marketCap":30717039},{"date":"2025-04-04","current":-3.66892,"twenty":-8.674369,"median":-5.166169,"eighty":-2.120821,"marketCap":26855468},{"date":"2025-04-11","current":-3.213302,"twenty":-8.66286,"median":-5.148914,"eighty":-2.122424,"marketCap":23520475},{"date":"2025-04-17","current":-2.619825,"twenty":-8.66286,"median":-5.027237,"eighty":-2.122424,"marketCap":24582850},{"date":"2025-04-25","current":-3.162503,"twenty":-8.674369,"median":-4.921084,"eighty":-2.120821,"marketCap":29675012},{"date":"2025-05-02","current":-2.301703,"twenty":-8.674369,"median":-4.808929,"eighty":-2.120821,"marketCap":21597790},{"date":"2025-05-09","current":-2.20104,"twenty":-8.674369,"median":-4.772307,"eighty":-2.120821,"marketCap":20653229},{"date":"2025-05-16","current":-2.138747,"twenty":-8.674369,"median":-4.713965,"eighty":-2.120821,"marketCap":20068704},{"date":"2025-05-23","current":-2.01416,"twenty":-8.674369,"median":-4.577753,"eighty":-2.103843,"marketCap":18899653},{"date":"2025-05-30","current":-2.149129,"twenty":-8.674369,"median":-4.556175,"eighty":-2.103843,"marketCap":20166125},{"date":"2025-06-06","current":-2.055896,"twenty":-8.674369,"median":-4.507162,"eighty":-2.088575,"marketCap":19291285},{"date":"2025-06-13","current":-2.117982,"twenty":-8.674369,"median":-4.460255,"eighty":-2.081572,"marketCap":19873862},{"date":"2025-06-20","current":-2.076453,"twenty":-8.685878,"median":-4.364336,"eighty":-2.076453,"marketCap":19484179},{"date":"2025-06-27","current":-1.784919,"twenty":-8.685878,"median":-4.348437,"eighty":-2.064664,"marketCap":16748600},{"date":"2025-07-03","current":-1.868808,"twenty":-8.685878,"median":-4.331537,"eighty":-2.055429,"marketCap":17535761},{"date":"2025-07-11","current":-1.868808,"twenty":-8.685878,"median":-4.302415,"eighty":-2.032165,"marketCap":17535761},{"date":"2025-07-18","current":-1.493881,"twenty":-8.685878,"median":-4.248124,"eighty":-2.018863,"marketCap":17016485},{"date":"2025-07-25","current":-1.734275,"twenty":-8.685878,"median":-4.239429,"eighty":-2.013867,"marketCap":19754770},{"date":"2025-08-01","current":-1.545394,"twenty":-8.649381,"median":-4.227439,"eighty":-2.007155,"marketCap":17603261},{"date":"2025-08-08","current":-1.425196,"twenty":-8.629173,"median":-4.182011,"eighty":-2.002261,"marketCap":16234118},{"date":"2025-08-15","current":-1.371966,"twenty":-8.629173,"median":-4.111394,"eighty":-1.993395,"marketCap":15627784},{"date":"2025-08-22","current":-1.349472,"twenty":-8.629173,"median":-4.083847,"eighty":-1.980278,"marketCap":15371558},{"date":"2025-08-29","current":-1.528223,"twenty":-8.629173,"median":-4.01548,"eighty":-1.970664,"marketCap":17407669},{"date":"2025-09-05","current":-1.657692,"twenty":-8.635361,"median":-3.967976,"eighty":-1.962047,"marketCap":18882431},{"date":"2025-09-12","current":-1.837301,"twenty":-8.629173,"median":-3.852892,"eighty":-1.951696,"marketCap":20928321},{"date":"2025-09-19","current":-2.094867,"twenty":-8.629173,"median":-3.800316,"eighty":-1.951696,"marketCap":23862198},{"date":"2025-09-26","current":-2.627169,"twenty":-8.629173,"median":-3.761195,"eighty":-1.951696,"marketCap":29925543},{"date":"2025-10-03","current":-1.527364,"twenty":-8.629173,"median":-3.688542,"eighty":-1.926272,"marketCap":17397889},{"date":"2025-10-10","current":-1.740679,"twenty":-8.629173,"median":-3.66892,"eighty":-1.912482,"marketCap":19827709},{"date":"2025-10-17","current":-1.610445,"twenty":-8.629173,"median":-3.607841,"eighty":-1.897885,"marketCap":18344245},{"date":"2025-10-24","current":-1.7768,"twenty":-8.629173,"median":-3.513775,"eighty":-1.888909,"marketCap":20239165},{"date":"2025-10-31","current":-1.920311,"twenty":-8.629173,"median":-3.453101,"eighty":-1.883018,"marketCap":21873867},{"date":"2025-11-07","current":-2.10873,"twenty":-8.629173,"median":-3.39874,"eighty":-1.883018,"marketCap":24020108},{"date":"2025-11-14","current":-2.147781,"twenty":-8.629173,"median":-3.373109,"eighty":-1.883018,"marketCap":24464925},{"date":"2025-11-21","current":-2.157543,"twenty":-8.629173,"median":-3.34321,"eighty":-1.883018,"marketCap":24576129},{"date":"2025-11-28","current":-2.035498,"twenty":-8.629173,"median":-3.278748,"eighty":-1.883018,"marketCap":24226172},{"date":"2025-12-05","current":-2.091521,"twenty":-8.629173,"median":-3.228187,"eighty":-1.883018,"marketCap":24892947},{"date":"2025-12-12","current":-2.296938,"twenty":-8.629173,"median":-3.175644,"eighty":-1.883018,"marketCap":27337790},{"date":"2025-12-19","current":-1.279376,"twenty":-8.629173,"median":-2.995852,"eighty":-1.874558,"marketCap":15226927},{"date":"2025-12-26","current":-1.170993,"twenty":-8.629173,"median":-2.889864,"eighty":-1.868808,"marketCap":13936969},{"date":"2026-01-02","current":-1.290183,"twenty":-8.629173,"median":-2.789026,"eighty":-1.863248,"marketCap":15355554},{"date":"2026-01-09","current":-1.453286,"twenty":-8.629173,"median":-2.742117,"eighty":-1.853183,"marketCap":17296774},{"date":"2026-01-16","current":-1.68535,"twenty":-8.629173,"median":-2.724952,"eighty":-1.842693,"marketCap":18190234},{"date":"2026-01-23","current":-1.884115,"twenty":-8.629173,"median":-2.698926,"eighty":-1.839412,"marketCap":20335532},{"date":"2026-01-30","current":-1.742996,"twenty":-8.629173,"median":-2.682082,"eighty":-1.830746,"marketCap":18812420},{"date":"2026-02-06","current":-1.526477,"twenty":-8.555297,"median":-2.647022,"eighty":-1.815946,"marketCap":16475489}],"updateTime":1770559408429},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LEXX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609112555","title":"Lexaria Bioscience Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2609112555","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609112555?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:31","pubTimestamp":1770413493,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has received a notification from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum $1.00 bid price requirement for continued listing on the Nasdaq Capital Market. The company has 180 calendar days, until August 3, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. If compliance is not regained within this period, Lexaria may be eligible for an additional 180-day extension, provided it meets other listing requirements and notifies Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split. Failure to comply could result in delisting, though the company would have the opportunity to appeal the decision.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL7S4Kwz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2609306742","title":"Lexaria Bioscience Reports Positive Results for Oral Liraglutide in Human Pilot Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306742","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609306742?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:15","pubTimestamp":1770300930,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has announced the final results from its Human Pilot Study #5 , evaluating oral DehydraTECH-liraglutide  capsules compared to injected Saxenda branded liraglutide . The study demonstrated broadly similar temporal patterns between oral DHT-LIR and injected SAX-LIR, with the primary safety and tolerability endpoint achieved. Lexaria reported that the oral formulation functioned comparably to the injected version, despite using a conservatively low dose of DHT-LIR. The company is considering further development and potential commercialization of the oral product through the 505 regulatory pathway and is in discussions with pharmaceutical partners. The results from this study have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL9RB1K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2607445347","title":"Lexaria Bioscience Corp. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2607445347","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607445347?lang=en_us&edition=fundamental","pubTime":"2026-01-29 02:51","pubTimestamp":1769626298,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. held its annual shareholder meeting on January 27, 2026. Shareholders approved the election of Richard Christopher, John Docherty, Christopher Bunka, Nicholas Baxter, William Edward  McKechnie, Albert Reese Jr., and Bal Bhullar as directors. The appointment of Malone Bailey LLP as auditors was approved. The ratification of the lawful actions of the directors for the past year was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 28, 2026, and is solely responsible for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDLKWNBK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2605238492","title":"Lexaria Bioscience Corp. Granted Six New Patents, Bringing Total to 60 Worldwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2605238492","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605238492?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:20","pubTimestamp":1769091614,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has announced the granting of six additional patents, bringing its total to 60 granted patents worldwide. Among the new patents, the company received one new US patent in its diabetes treatment family, its first Australian patent for sublingual nicotine delivery, and its first European Union patent for hypertension treatment. Additionally, two new Australian patents and one European Union patent were granted for epilepsy treatment, further strengthening Lexaria's intellectual property portfolio in these areas.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via ACCESS Newswire  on January 22, 2026, and is solely responsible ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL6X84lM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2603308756","title":"Lexaria Bioscience Q1 net loss narrows to USD 1.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2603308756","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603308756?lang=en_us&edition=fundamental","pubTime":"2026-01-14 04:21","pubTimestamp":1768335695,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. reported its financial results for the three months ended November 30, 2025. The company recorded a net loss of USD 1.6 million for the period. Research and development expenses decreased year-over-year by USD 1.3 million as Lexaria neared completion of its Phase 1b Clinical Trial . Consulting fees and salaries increased by USD 31 thousand, primarily due to cost of living salary adjustments. During the quarter, the company raised USD 3.4 million in net proceeds from a Registered Direct offering completed in September 2025. Lexaria continues to focus on the optimization of its DehydraTECH formulations within its pharmaceutical division.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. publ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL7WBJnz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2602549193","title":"Lexaria CEO says ‘closer to a commercial breakthrough than ever before’","url":"https://stock-news.laohu8.com/highlight/detail?id=2602549193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602549193?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:50","pubTimestamp":1768229408,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience (LEXX) provided an Annual Letter from its CEO Richard Christopher as a strategic update to all stakeholders, which read in part,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexaria-ceo-says-closer-to-a-commercial-breakthrough-than-ever-before-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexaria-ceo-says-closer-to-a-commercial-breakthrough-than-ever-before-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2602545398","title":"Lexaria Bioscience Corp. Pursues Pharmaceutical Partnerships and Reports Progress on Technology Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2602545398","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602545398?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:10","pubTimestamp":1768227017,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. released its Annual Letter from the CEO, outlining the company's progress during 2025. The letter reported significant advancements in oral-based drug delivery within the GLP-1 sector using Lexaria's proprietary DehydraTECH technology. Multiple human and animal studies conducted and concluded in 2025 demonstrated encouraging results in safety, tolerability, pharmacokinetics, weight loss, blood glucose, insulin, biodistribution, and blood pressure. The company also noted ongoing efforts to attract potential partners, although it acknowledged the pharmaceutical industry’s lengthy evaluation processes. Further strategic updates and plans for 2026 were also referenced.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL6Mhxr0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2595371895","title":"Lexaria Bioscience Reports Positive Results from Phase 1b GLP-1-H24-4 Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2595371895","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595371895?lang=en_us&edition=fundamental","pubTime":"2025-12-30 22:20","pubTimestamp":1767104414,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has released additional results from its Phase 1b clinical study, GLP-1-H24-4, recently completed in Australia. The study evaluated four DehydraTECH  study arms in comparison to the Rybelsus control arm over a 12-week period. According to the company, secondary efficacy parameters assessed at week 16—such as mean fasting glucose, cholesterol, and LDL cholesterol—showed no statistically significant differences between the DHT arms and the Rybelsus control. Lexaria stated that the complete study report exceeds 7,000 pages and that additional details are under review. The company also indicated plans for further clinical testing and research in the GLP-1 sector, with updates on development opportunities expected in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLbj5Tnq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2594958752","title":"Lexaria Bioscience Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2594958752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594958752?lang=en_us&edition=fundamental","pubTime":"2025-12-26 19:17","pubTimestamp":1766747820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEXX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 26, 2025 06:17 ET (11:17 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2594293724","title":"Lexaria Bioscience Corp. : H.c. Wainwright Cuts Target Price to $1.5 From $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2594293724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594293724?lang=en_us&edition=fundamental","pubTime":"2025-12-26 19:05","pubTimestamp":1766747139,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nAZN4RKH93:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2593144214","title":"Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus","url":"https://stock-news.laohu8.com/highlight/detail?id=2593144214","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593144214?lang=en_us&edition=fundamental","pubTime":"2025-12-24 01:06","pubTimestamp":1766509560,"startTime":"0","endTime":"0","summary":"Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with comparable HbA1c results in a Phase 1b study.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/23/Konskie--Poland---January-11--2024-Novo-_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/23/Konskie--Poland---January-11--2024-Novo-_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49566831/lexaria-says-oral-glp-1-cuts-side-effects-nearly-50-versus-novo-nordisks-rybelsus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49566831/lexaria-says-oral-glp-1-cuts-side-effects-nearly-50-versus-novo-nordisks-rybelsus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4144","BK4599","LU0154236417.USD","BK4188","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4590","IE00BKVL7J92.USD","BK4585","BK4007","BK4588","LEXX","BK4532"],"gpt_icon":1},{"id":"2593441543","title":"Lexaria Bioscience Achieves Primary Endpoint in GLP-1 Clinical Study with DehydraTECH Outperforming Rybelsus","url":"https://stock-news.laohu8.com/highlight/detail?id=2593441543","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593441543?lang=en_us&edition=fundamental","pubTime":"2025-12-23 22:29","pubTimestamp":1766500155,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has announced the public release of final results from its clinical study GLP-1-H24-4, conducted in Australia. The study focused on four DehydraTECH  study arms compared to the Rybelsus control arm, targeting improvements in safety and tolerability for oral GLP-1 medications. Lexaria reported achieving its primary endpoint, with data indicating a significant reduction in gastrointestinal side effects—by approximately half—relative to Rybelsus. The company will now provide the full dataset to its pharmaceutical partner under an existing Material Transfer Agreement, recently extended through April 30, 2026, for further review and evaluation. Lexaria is also considering additional human clinical testing with a DehydraTECH + SNAC + semaglutide composition, building on results from previous studies. Further details on prospective research activities will be announced if and when plans are finalized.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDLrtHnp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2592922937","title":"Lexaria Bioscience Issues Warrants to Purchase 2.66 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592922937","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592922937?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:06","pubTimestamp":1765919182,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has announced a definitive agreement for a registered direct offering involving the sale of 2,661,600 shares of its common stock at $1.315 per share. In a concurrent private placement, the company will issue unregistered warrants to purchase up to 2,661,600 shares of common stock at an exercise price of $1.19 per share. The warrants will be immediately exercisable and will expire five years from the date the resale registration statement becomes effective. The offering is expected to close on or about December 16, 2025, subject to customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via EDGAR, the El","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL2sGYzY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2591626349","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2591626349","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591626349?lang=en_us&edition=fundamental","pubTime":"2025-12-16 02:22","pubTimestamp":1765822969,"startTime":"0","endTime":"0","summary":"iRobot  shares plunged 71% amid heavy trading after the company filed for bankruptcy protection on Sunday.Almost 89.7 million shares of the company traded intraday compared with a daily average of 14.7 million.Lexaria Bioscience  said Monday it has signed a definitive agreement to sell more than 2.66 million shares at $1.315 apiece in a registered direct offering.Shares of the company slumped 34% as intraday trading volume rose to nearly 1.17 million from a daily average of about 578,000.ServiceNow  is in late-stage talks to buy cybersecurity company Armis for up to $7 billion, Bloomberg reported Sunday, citing people familiar with the matter.Shares of ServiceNow dropped about 12% as intraday trading volume soared to nearly 3.12 million from a daily average of over 1.42 million.Price: 1.23, Change: -3.09, Percent Change: -71.57","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU2125909247.SGD","LU2286300806.USD","LU2125909759.SGD","LU0708995401.HKD","LU2458330169.SGD","LU0943347566.SGD","LU2125909916.SGD","BK4585","LU0354030438.USD","LU2023250504.SGD","BK4550","BK4097","LU0082616367.USD","LU2543165471.USD","LU1989764748.USD","BK4547","BK4608","LU1974910355.USD","IE00BZ9MQY76.HKD","LU0348723411.USD","LU1116320901.HKD","LU2023251221.USD","BK4604","LU1917777945.USD","LU1989772923.USD","BK4543","BK4607","IE00B19Z9Z06.USD","LU2023250843.SGD","IRBT","BK4581","LU0109391861.USD","BK4503","LU0353189763.USD","BK4566","LEXX","LU2028103732.USD","LU1951198990.SGD","NOW","LU1267930730.SGD","LU0823434583.USD","BK4613","LU1923622614.USD","LU1923623000.USD","LU2271345857.HKD","LU2106854487.HKD","IRBTQ","LU1551013342.USD","LU1551013425.SGD","LU0820561818.USD"],"gpt_icon":1},{"id":"2586786764","title":"Lexaria Bioscience FY IP Licensing Revenue Rises to USD 0.7 Million, Up 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586786764","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586786764?lang=en_us&edition=fundamental","pubTime":"2025-11-28 19:03","pubTimestamp":1764327810,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. reported a net loss of USD 11.9 million for the full year ended August 31, 2025. This compares to a net loss of USD 5.8 million in the previous year. IP Licensing revenue for the period was USD 0.7 million, representing an increase of 52 percent. B2B revenue totaled USD 9,923. The company stated that its existing cash and anticipated inflows from license agreements are not expected to meet operational requirements for the next twelve months, raising substantial doubt about its ability to continue as a going concern. Since entering the bioscience sector, Lexaria has accumulated net losses of USD 63.5 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content u","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL10SslL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2582722663","title":"Lexaria Bioscience Extends Material Transfer Agreement with Pharmaceutical Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2582722663","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582722663?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:10","pubTimestamp":1762956620,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has extended its Material Transfer Agreement with an unnamed pharmaceutical company  to evaluate Lexaria's DehydraTECHTM technology in a pre-clinical setting. The agreement, originally signed in September 2024, will now run through April 30, 2026, allowing PharmaCO additional time to review data from Lexaria's Australian human clinical study. The extension maintains a temporary exclusive license and enables ongoing strategic discussions between the two companies as they consider further collaboration in human clinical development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via ACCESS Newswire  on November 12, 2025, and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLbJG6WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2574168510","title":"Lexaria Bioscience Corp. Awarded Four New Patents Covering Diabetes, Epilepsy, Antiviral Treatments, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2574168510","media":"Reuters","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574168510?lang=en_us&edition=fundamental","pubTime":"2025-10-09 21:20","pubTimestamp":1760016016,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp. has announced the issuance of four new patents supporting its intellectual property portfolio. The newly granted patents cover a range of therapeutic applications, including treatments for epilepsy, diabetes, and enhanced delivery of antiviral agents, as well as compositions and methods for food and beverage products infused with lipophilic active agents. These patents are expected to support ongoing research and development programs in key therapeutic areas such as diabetes, hypertension, seizure disorders, and antiviral treatments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via ACCESS Newswire  on October 09, 2025, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL5rMlXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2571366456","title":"BRIEF-Lexaria Bioscience enters securities purchase agreement with investors - SEC filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2571366456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571366456?lang=en_us&edition=fundamental","pubTime":"2025-09-30 06:28","pubTimestamp":1759184900,"startTime":"0","endTime":"0","summary":"BRIEF-Lexaria Bioscience enters securities purchase agreement with investors - SEC filingSept 29  - Lexaria Bioscience Corp LEXX.O:LEXARIA BIOSCIENCE CORP - ENTERS SECURITIES PURCHASE AGREEMENT WITH INVESTORS - SEC FILINGSource text: [ID:n0001640334-25-001742]Further company coverage: LEXX.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VG0IC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2571636273","title":"Lexaria Bioscience Corp - Enters Securities Purchase Agreement With Investors - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2571636273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571636273?lang=en_us&edition=fundamental","pubTime":"2025-09-30 05:06","pubTimestamp":1759179996,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VG0IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2570397948","title":"Nasdaq Gains 100 Points; US Consumer Sentiment Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2570397948","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570397948?lang=en_us&edition=fundamental","pubTime":"2025-09-27 02:43","pubTimestamp":1758912223,"startTime":"0","endTime":"0","summary":"U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday.\n\n\n\nThe Dow traded up 0.83% to 46,328.48 while the NASDAQ rose 0.45% to 22,484.92. The S&amp;P 500 also rose, gaining, 0.62% to 6,645.73.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/09/47898757/nasdaq-gains-100-points-us-consumer-sentiment-falls","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPOP","BK4108","USJW.SI","BK4565","BK4122","BIAF","BK4141","MNQmain","KUKE","TSYW.SI","BK4539","TQQQ","BK4192","SQQQ","USAW.SI","BK4007","QLD","PSQ","QID","LEXX","NQmain","BK4139","BK4571","PCOM","NVIW.SI","BK4510",".IXIC","MRM"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}